Canadian Monitoring Program for Surface Contamination with 11 Antineoplastic Drugs in 126 Centres: Results for 2023

Canadian Journal of Hospital Pharmacy · Published 2025-05-14 · DOI 10.4212/cjhp.3671

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.4212/cjhp.3671

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Characteristics and Factors Influencing Clinical Pharmacy Services in Small Hospitals in British Columbia: A Theory-Informed Survey · Canadian Journal of Hospital Pharmacy · 2025 · Same journal
• Interaction between Carbamazepine and Concomitant Levetiracetam Therapy in Patients with Epilepsy · Canadian Journal of Hospital Pharmacy · 2025 · Same journal
• Spécialistes en pharmacothérapie : notre savoir-faire nous appartient! · Canadian Journal of Hospital Pharmacy · 2025 · Same journal
• A Farewell to Readers · Canadian Journal of Hospital Pharmacy · 2026 · Same journal
• Exploring Polypharmacy in the BC Correctional Health Setting · Canadian Journal of Hospital Pharmacy · 2025 · Same journal
• What Clinical Pharmacy Key Performance Indicator Processes of Care Were Patients Receiving across Canada in 2018? A National Patient Registry and Pooled Analysis · Canadian Journal of Hospital Pharmacy · 2025 · Same journal
• Pharmacotherapy Specialists: Let Us Own Our Area of Expertise! · Canadian Journal of Hospital Pharmacy · 2025 · Same journal
• Clinical Pharmacists’ Activities and Patient Outcomes in an Adult Congenital Heart Disease Clinic · Canadian Journal of Hospital Pharmacy · 2025 · Same journal
• An Innovative Approach to Interdisciplinary Training: A Pharmacy Resident’s Day with a Critical Care Nurse · Canadian Journal of Hospital Pharmacy · 2025 · Same journal
• Un adieu aux lecteurs · Canadian Journal of Hospital Pharmacy · 2026 · Same journal